Peregrine Pharmaceuticals (PPHM) announced that it lost $4.9 million, or 4 cents per share, during the quarter ending on January 31. The company lost $11.1 million, or 13 cents per share, in the same period last year, and revenue increased to $7 million from $3.3 million. Analysts had expected a loss of 7 cents per share on $4.1 million in revenue.
Shares are higher in early trading.
Synergetics (NASDAQ:SURG) announced that it lost $1.4 million during the fiscal second quarter versus earnings of $1.9 million in the same period last year due to lower sales as well as higher sales costs. Net sales were $14.1 million, down by 7 percent from $15.1 million during the second quarter of 2012.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.